Novelix Pharmaceuticals Ltd — Important, 12-02-2026: Company Update

Novelix Pharmaceuticals has completed a preferential issue, allotting 23.20 lakh equity shares at Rs. 60 each to 36 investors, including both promoter and non-promoter groups. This strategic move raised Rs. 13.92 crore for the company. Consequently, the paid-up equity capital has increased from Rs. 17.615 crore (17.615 million shares) to Rs. 19.935 crore (19.935 million shares). This capital infusion strengthens the company's financial position, providing funds for its operations and growth initiatives.